• Abramson, J., Adler, J., Dunger, J., Evans, R., Green, T., Pritzel, A., Ronneberger, O., Willmore, L., Ballard, A.J., Bambrick, J., Bodenstein, S.W., Evans, D.A., Hung, C.C., O'Neill, M., Reiman, D., Tunyasuvunakool, K., Wu, Z., Zemgulyte, A., Arvaniti, E., Beattie, C., Bertolli, O., Bridgland, A., Cherepanov, A., Congreve, M., Cowen-Rivers, A.I., Cowie, A., Figurnov, M., Fuchs, F.B., Gladman, H., Jain, R., Khan, Y.A., Low, C.M.R., Perlin, K., Potapenko, A., Savy, P., Singh, S., Stecula, A., Thillaisundaram, A., Tong, C., Yakneen, S., Zhong, E.D., Zielinski, M., Zidek, A., Bapst, V., Kohli, P., Jaderberg, M., Hassabis, D., Jumper, J.M., 2024. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493-500.

  • Aichem, A., Anders, S., Catone, N., Rossler, P., Stotz, S., Berg, A., Schwab, R., Scheuermann, S., Bialas, J., Schutz-Stoffregen, M.C., Schmidtke, G., Peter, C., Groettrup, M., Wiesner, S., 2018. The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation. Nature communications 9, 3321.

  • Aichem, A., Groettrup, M., 2020. The ubiquitin-like modifier FAT10 - much more than a proteasome-targeting signal. Journal of cell science 133.

  • Aichem, A., Pelzer, C., Lukasiak, S., Kalveram, B., Sheppard, P.W., Rani, N., Schmidtke, G., Groettrup, M., 2010. USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis. Nature communications 1, 13.

  • Ali, A., Farooqui, S.R., Banerjea, A.C., 2019. The host cell ubiquitin ligase protein CHIP is a potent suppressor of HIV-1 replication. The Journal of biological chemistry 294, 7283-7295.

  • Ali, A., Mishra, R., Kaur, H., Chandra Banerjea, A., 2021. HIV-1 Tat: An update on transcriptional and non-transcriptional functions. Biochimie 190, 24-35.

  • Ali, A., Raja, R., Farooqui, S.R., Ahmad, S., Banerjea, A.C., 2017. USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein. The Biochemical journal 474, 1653-1668.

  • Bialas, J., Boehm, A.N., Catone, N., Aichem, A., Groettrup, M., 2019. The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1. The Journal of biological chemistry 294, 4315-4330.

  • Chou, T.C., Maggirwar, N.S., Marsden, M.D., 2024. HIV Persistence, Latency, and Cure Approaches: Where Are We Now? Viruses 16.

  • D'Orso, I., 2025. The HIV-1 Transcriptional Program: From Initiation to Elongation Control. Journal of molecular biology 437, 168690.

  • Faust, T.B., Li, Y., Jang, G.M., Johnson, J.R., Yang, S., Weiss, A., Krogan, N.J., Frankel, A.D., 2017. PJA2 ubiquitinates the HIV-1 Tat protein with atypical chain linkages to activate viral transcription. Scientific reports 7, 45394.

  • Gao, W., Li, G., Zhao, S., Wang, H., Huan, C., Zheng, B., Jiang, C., Zhang, W., 2021. Deubiquitinating Enzyme USP21 Inhibits HIV-1 Replication by Downregulating Tat Expression. Journal of virology 95, e0046021.

  • Garber, M.E., Wei, P., KewalRamani, V.N., Mayall, T.P., Herrmann, C.H., Rice, A.P., Littman, D.R., Jones, K.A., 1998. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes & development 12, 3512-3527.

  • GBD 2021 HIV Collaborators, 2024. Global, regional, and national burden of HIV/AIDS, 1990-2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021. The lancet. HIV 11, e807-e822.

  • Hetzer, C., Dormeyer, W., Schnolzer, M., Ott, M., 2005. Decoding Tat: the biology of HIV Tat posttranslational modifications. Microbes and infection 7, 1364-1369.

  • Hipp, M.S., Kalveram, B., Raasi, S., Groettrup, M., Schmidtke, G., 2005. FAT10, a ubiquitin-independent signal for proteasomal degradation. Molecular and cellular biology 25, 3483-3491.

  • Kessing, C.F., Nixon, C.C., Li, C., Tsai, P., Takata, H., Mousseau, G., Ho, P.T., Honeycutt, J.B., Fallahi, M., Trautmann, L., Garcia, J.V., Valente, S.T., 2017. In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a "Block-and-Lock" Strategy for HIV-1 Treatment. Cell reports 21, 600-611.

  • Liang, T., Zhang, Q., Wu, Z., Chen, P., Huang, Y., Liu, S., Li, L., 2021. UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat. mBio 12, e0162521.

  • Liu, X., Chen, L., Ge, J., Yan, C., Huang, Z., Hu, J., Wen, C., Li, M., Huang, D., Qiu, Y., Hao, H., Yuan, R., Lei, J., Yu, X., Shao, J., 2016. The Ubiquitin-like Protein FAT10 Stabilizes eEF1A1 Expression to Promote Tumor Proliferation in a Complex Manner. Cancer research 76, 4897-4907.

  • Liu, Y.C., Pan, J., Zhang, C., Fan, W., Collinge, M., Bender, J.R., Weissman, S.M., 1999. A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2. Proceedings of the National Academy of Sciences of the United States of America 96, 4313-4318.

  • Lukasiak, S., Schiller, C., Oehlschlaeger, P., Schmidtke, G., Krause, P., Legler, D.F., Autschbach, F., Schirmacher, P., Breuhahn, K., Groettrup, M., 2008. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene 27, 6068-6074.

  • Margolis, D.M., Browne, E.P., 2025. The role of Tat in HIV latency and reactivation. Frontiers in immunology 16, 1650385.

  • Matsuda, K., Maeda, K., 2024. HIV Reservoirs and Treatment Strategies toward Curing HIV Infection. International journal of molecular sciences 25.

  • McGirr, T., Onar, O., Jafarnejad, S.M., 2025. Dysregulated ribosome quality control in human diseases. The FEBS journal 292, 936-959.

  • Mousseau, G., Kessing, C.F., Fromentin, R., Trautmann, L., Chomont, N., Valente, S.T., 2015. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency. mBio 6, e00465.

  • Nair, M., Gettins, L., Fuller, M., Kirtley, S., Hemelaar, J., 2024. Global and regional genetic diversity of HIV-1 in 2010-21: systematic review and analysis of prevalence. The Lancet. Microbe 5, 100912.

  • Ott, M., Geyer, M., Zhou, Q., 2011. The control of HIV transcription: keeping RNA polymerase II on track. Cell host & microbe 10, 426-435.

  • Rahman, S., Wolberger, C., 2024. Breaking the K48-chain: linking ubiquitin beyond protein degradation. Nature structural & molecular biology 31, 216-218.

  • Ramakrishnan, R., Chiang, K., Liu, H., Budhiraja, S., Donahue, H., Rice, A.P., 2012. Making a Short Story Long: Regulation of P-TEFb and HIV-1 Transcriptional Elongation in CD4+ T Lymphocytes and Macrophages. Biology 1, 94-115.

  • Ran, F.A., Hsu, P.D., Wright, J., Agarwala, V., Scott, D.A., Zhang, F., 2013. Genome engineering using the CRISPR-Cas9 system. Nature protocols 8, 2281-2308.

  • Schmidtke, G., Aichem, A., Groettrup, M., 2014. FAT10ylation as a signal for proteasomal degradation. Biochimica et biophysica acta 1843, 97-102.

  • Shepherd, R.A., Tanaka, K., King, H.A.D., Schou, M.D., Lloyd Williams, O.H., Kim, Y., Roche, M., Lewin, S.R., 2025. Host-directed approaches in the pursuit of a cure for HIV. Antiviral research 240, 106216.

  • Shi, H., Hou, Y., Wang, H., Huan, C., Wang, Y., Wang, H., Zhang, W., 2026. Zinc finger protein 598 promotes HIV-1 replication and latent reactivation by stabilizing the expression of viral trans-activator of transcription Tat. International journal of biological macromolecules 353, 151322.

  • Wang, G., Kouwaki, T., Okamoto, M., Oshiumi, H., 2019. Attenuation of the Innate Immune Response against Viral Infection Due to ZNF598-Promoted Binding of FAT10 to RIG-I. Cell reports 28, 1961-1970.e1964.

  • Wang, H., Liu, Y., Huan, C., Yang, J., Li, Z., Zheng, B., Wang, Y., Zhang, W., 2020. NF-κB-Interacting Long Noncoding RNA Regulates HIV-1 Replication and Latency by Repressing NF-κB Signaling. Journal of virology 94.

  • Xu, M., Hu, H., Yang, W., Zhang, J., Wang, H., Zhang, W., Huan, C., 2025. FBXO45 restricts HIV-1 replication by inducing SQSTM1/p62-mediated autophagic degradation of Tat. Journal of virology 99, e0191224.

  • Yang, W., Wang, H., Li, Z., Zhang, L., Liu, J., Kirchhoff, F., Huan, C., Zhang, W., 2024. RPLP1 restricts HIV-1 transcription by disrupting C/EBPβ binding to the LTR. Nature communications 15, 5290.

  • Yuan, R., Wang, K., Hu, J., Yan, C., Li, M., Yu, X., Liu, X., Lei, J., Guo, W., Wu, L., Hong, K., Shao, J., 2014. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation. Cancer research 74, 5287-5300.

  • Zhou, Q., Chen, D., Pierstorff, E., Luo, K., 1998. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. The EMBO journal 17, 3681-3691.

  • Zhu, J., Zhao, J., Luo, C., Zhu, Z., Peng, X., Zhu, X., Lin, K., Bu, F., Zhang, W., Li, Q., Wang, K., Hu, Z., Yu, X., Chen, L., Yuan, R., 2022. FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression. Cell death & disease 13, 497.